Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [1] Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies
    Sun, Jian-Xuan
    Liu, Chen-Qian
    Zhong, Xing-Yu
    Xu, Jin-Zhou
    An, Ye
    Xu, Meng-Yao
    Hu, Jia
    Zhang, Zong-Biao
    Xia, Qi-Dong
    Wang, Shao-Gang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] The association of statin use and biochemical recurrence after curative treatment for prostate cancer A systematic review and meta-analysis
    Yin, Peng
    Han, Sheng
    Hu, Qingfeng
    Tong, Shijun
    MEDICINE, 2022, 101 (01) : E28513
  • [3] The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis
    Tan, Ping
    Wei, Shiyou
    Yang, Lu
    Tang, Zhuang
    Cao, Dehong
    Liu, Liangren
    Lei, Junhao
    Fan, Yu
    Gao, Liang
    Wei, Qiang
    SCIENTIFIC REPORTS, 2016, 6
  • [4] Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
    Hua, Qingling
    Zhu, Yanzhe
    Liu, Hu
    Ye, Xiaobing
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (09) : 1437 - 1443
  • [5] Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis
    Meng, Yang
    Liao, Yan-Biao
    Xu, Peng
    Wei, Wu-Ran
    Wang, Jia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 13267 - 13274
  • [6] Statin use and risk of gastrointestinal cancer: a meta-analysis of cohort studies
    You, Shanxi
    Sun, Genlin
    Yao, Qingchun
    Wan, Zhenzhou
    Huang, Xinen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 1437 - 1447
  • [7] Metformin use and prostate cancer risk A meta-analysis of cohort studies
    Feng, Zhaohan
    Zhou, Xiaofeng
    Liu, Naibo
    Wang, Jianfeng
    Chen, Xing
    Xu, Xin
    MEDICINE, 2019, 98 (12)
  • [8] The association of statin use with risk of kidney, bladder and prostate cancer: a systematic review and meta-analysis of cohort studies
    Chen, Jiabi
    Zhang, Bing
    Chen, Dong
    Zhuang, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (09): : 8873 - 8885
  • [9] The Prognostic Association of Prostate MRI PI-RADS™ v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis
    Rajwa, Pawel
    Mori, Keiichiro
    Huebner, Nicolai A.
    Martin, Darryl T.
    Sprenkle, Preston C.
    Weinreb, Jeffrey C.
    Ploussard, Guillaume
    Pradere, Benjamin
    Shariat, Shahrokh F.
    Leapman, Michael S.
    JOURNAL OF UROLOGY, 2021, 206 (03) : 508 - 516
  • [10] Impact of statin use on cancer-specific mortality and recurrence A meta-analysis of 60 observational studies
    Yang, Jing
    Li, Chunyu
    Shen, Ying
    Zhou, Hong
    Shao, Yueqin
    Zhu, Wei
    Chen, Yan
    MEDICINE, 2020, 99 (14)